Oritavancin Diphosphate | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Oritavancin Diphosphate
U.S. EXCLUSIVITIES

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Oritavancin Diphosphate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 NDC API, $ API Reference Price

1 NDC API
$ API Reference Price

FINISHED DOSAGE FORMULATIONS

3 FDF Dossiers, 2 FDA Orange Book, 1 Europe

3 FDF Dossiers
2 FDA Orange Book
1 Europe

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 12 SPI Pharma, 1 Pfanstiehl, 1 BASF, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 2 Kerry, 2 Microlex e.U, 1 Pluviaendo, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

1 Rochem International Inc
12 SPI Pharma
1 Pfanstiehl
1 BASF
2 Gangwal Chemicals
1 Ingredion Pharma Solutions
2 Kerry
2 Microlex e.U
1 Pluviaendo
3 Roquette
1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 10 Chewable & Orodispersible Aids, 9 Taste Masking, 9 Direct Compression, 4 Parenteral, 3 Disintegrants & Superdisintegrants, 3 Co-Processed Excipients, 3 Granulation, 1 API Stability Enhancers, 1 Thickeners and Stabilizers

17 Fillers, Diluents & Binders
10 Chewable & Orodispersible Aids
9 Taste Masking
9 Direct Compression
4 Parenteral
3 Disintegrants & Superdisintegrants
3 Co-Processed Excipients
3 Granulation
1 API Stability Enhancers
1 Thickeners and Stabilizers

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 1 NEWS #PharmaBuzz

3 DATA COMPILATION #PharmaFlow
1 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

1 US Medicaid Prescriptions

MARKET PLACE

4 APIs

4 APIs

PATENTS & EXCLUSIVITIES

6 US Patents, 5 US Exclusivities

6 US Patents
5 US Exclusivities

$ API Ref.Price (USD/KG) : 98,243 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

5 All

01 5MELINTA THERAP

filter Product Reset all filters

5 All

01 5ORITAVANCIN DIPHOSPHATE

filter Exclusivity Expiration Date Reset all filters

5 All

01 22019-08-06

02 12024-03-12

03 22024-08-06

filter Exclusivity Code Reset all filters

5 All

01 2GAIN

02 2NCE

03 1NP

Product Main Page

MELINTA THERAP

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

ORITAVANCIN DIPHOSPHATE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

GAIN

Exclusivity Expiration Date

2024-08-06

Application Number

214155

Product Number

1

Exclusivity Details

01

MELINTA THERAP

ORITAVANCIN DIPHOSPHATE

2024 ACI Convention

Not Confirmed

MELINTA THERAP

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ORITAVANCIN DIPHOSPHATE

Exclusivity Code : GAIN

Exclusivity Expiration Date : 2024-08-06

Application Number : 214155

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

MELINTA THERAP

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

ORITAVANCIN DIPHOSPHATE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

GAIN

Exclusivity Expiration Date

2024-08-06

Application Number

206334

Product Number

1

Exclusivity Details

02

MELINTA THERAP

ORITAVANCIN DIPHOSPHATE

2024 ACI Convention

Not Confirmed

MELINTA THERAP

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ORITAVANCIN DIPHOSPHATE

Exclusivity Code : GAIN

Exclusivity Expiration Date : 2024-08-06

Application Number : 206334

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

MELINTA THERAP

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

ORITAVANCIN DIPHOSPHATE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

NCE

Exclusivity Expiration Date

2019-08-06

Application Number

214155

Product Number

1

Exclusivity Details

03

MELINTA THERAP

ORITAVANCIN DIPHOSPHATE

2024 ACI Convention

Not Confirmed

MELINTA THERAP

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ORITAVANCIN DIPHOSPHATE

Exclusivity Code : NCE

Exclusivity Expiration Date : 2019-08-06

Application Number : 214155

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

MELINTA THERAP

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

ORITAVANCIN DIPHOSPHATE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

NP

Exclusivity Expiration Date

2024-03-12

Application Number

214155

Product Number

1

Exclusivity Details

04

MELINTA THERAP

ORITAVANCIN DIPHOSPHATE

2024 ACI Convention

Not Confirmed

MELINTA THERAP

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ORITAVANCIN DIPHOSPHATE

Exclusivity Code : NP

Exclusivity Expiration Date : 2024-03-12

Application Number : 214155

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

MELINTA THERAP

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

ORITAVANCIN DIPHOSPHATE

Portfolio PDF

Product Web Link

Digital Content

Exclusivity Code

NCE

Exclusivity Expiration Date

2019-08-06

Application Number

206334

Product Number

1

Exclusivity Details

05

MELINTA THERAP

ORITAVANCIN DIPHOSPHATE

2024 ACI Convention

Not Confirmed

MELINTA THERAP

U.S.A

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ORITAVANCIN DIPHOSPHATE

Exclusivity Code : NCE

Exclusivity Expiration Date : 2019-08-06

Application Number : 206334

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?